467 related articles for article (PubMed ID: 17762780)
1. Mosquito stage, transmission blocking vaccines for malaria.
Saul A
Curr Opin Infect Dis; 2007 Oct; 20(5):476-81. PubMed ID: 17762780
[TBL] [Abstract][Full Text] [Related]
2. Development of malaria vaccines that block transmission of parasites by mosquito vectors.
Hisaeda H; Yasutomo K
J Med Invest; 2002 Aug; 49(3-4):118-23. PubMed ID: 12323000
[TBL] [Abstract][Full Text] [Related]
3. Mosquito-based transmission blocking vaccines for interrupting Plasmodium development.
Lavazec C; Bourgouin C
Microbes Infect; 2008 Jul; 10(8):845-9. PubMed ID: 18656409
[TBL] [Abstract][Full Text] [Related]
4. Efficacy model for mosquito stage transmission blocking vaccines for malaria.
Saul A
Parasitology; 2008 Nov; 135(13):1497-506. PubMed ID: 18257944
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines.
Saxena AK; Wu Y; Garboczi DN
Eukaryot Cell; 2007 Aug; 6(8):1260-5. PubMed ID: 17557884
[No Abstract] [Full Text] [Related]
6. A mathematical model studying mosquito-stage transmission-blocking vaccines.
Zhao R; Mohammed-Awel J
Math Biosci Eng; 2014 Oct; 11(5):1229-45. PubMed ID: 25347811
[TBL] [Abstract][Full Text] [Related]
7. The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms.
Saxena AK; Singh K; Su HP; Klein MM; Stowers AW; Saul AJ; Long CA; Garboczi DN
Nat Struct Mol Biol; 2006 Jan; 13(1):90-1. PubMed ID: 16327807
[TBL] [Abstract][Full Text] [Related]
8. Asexual blood-stage malaria vaccine development: facing the challenges.
Genton B; Reed ZH
Curr Opin Infect Dis; 2007 Oct; 20(5):467-75. PubMed ID: 17762779
[TBL] [Abstract][Full Text] [Related]
9. Toward the development of effective transmission-blocking vaccines for malaria.
Nikolaeva D; Draper SJ; Biswas S
Expert Rev Vaccines; 2015 May; 14(5):653-80. PubMed ID: 25597923
[TBL] [Abstract][Full Text] [Related]
10. Transmission-blocking vaccines: uses and current status of development.
Kaslow DC
Int J Parasitol; 1997 Feb; 27(2):183-9. PubMed ID: 9088989
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate.
Tachibana M; Sato C; Otsuki H; Sattabongkot J; Kaneko O; Torii M; Tsuboi T
Vaccine; 2012 Feb; 30(10):1807-12. PubMed ID: 22245309
[TBL] [Abstract][Full Text] [Related]
12. Chimeric parasites as tools to study Plasmodium immunology and assess malaria vaccines.
Cockburn I
Methods Mol Biol; 2013; 923():465-79. PubMed ID: 22990798
[TBL] [Abstract][Full Text] [Related]
13. Strategies & recent development of transmission-blocking vaccines against
Chaturvedi N; Bharti PK; Tiwari A; Singh N
Indian J Med Res; 2016 Jun; 143(6):696-711. PubMed ID: 27748294
[TBL] [Abstract][Full Text] [Related]
14. Current developments in malaria transmission-blocking vaccines.
Stowers A; Carter R
Expert Opin Biol Ther; 2001 Jul; 1(4):619-28. PubMed ID: 11727498
[TBL] [Abstract][Full Text] [Related]
15. Transmission blocking malaria vaccines.
Carter R
Vaccine; 2001 Mar; 19(17-19):2309-14. PubMed ID: 11257353
[TBL] [Abstract][Full Text] [Related]
16. Preerythrocytic malaria vaccine development.
Mikolajczak SA; Aly AS; Kappe SH
Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
[TBL] [Abstract][Full Text] [Related]
17. Targeting Plasmodium liver stages: better late than never.
Borrmann S; Matuschewski K
Trends Mol Med; 2011 Sep; 17(9):527-36. PubMed ID: 21737347
[TBL] [Abstract][Full Text] [Related]
18. Vaccines. Searching for a parasite's weak spot.
Taubes G
Science; 2000 Oct; 290(5491):434-7. PubMed ID: 11183756
[TBL] [Abstract][Full Text] [Related]
19. Transmission blocking malaria vaccines: Assays and candidates in clinical development.
Sauerwein RW; Bousema T
Vaccine; 2015 Dec; 33(52):7476-82. PubMed ID: 26409813
[TBL] [Abstract][Full Text] [Related]
20. Mosquito production mooted as fast track to malaria vaccine.
Butler D
Nature; 2003 Oct; 425(6957):437. PubMed ID: 14523404
[No Abstract] [Full Text] [Related]
[Next] [New Search]
